CompletedObservationalLast updated Mar 12, 2018

Nicotine Receptor Levels and Smoking Cessation

Nicotinic Receptor Availability and Smoking Cessation Success.

Overview

ClinicalTrials.gov ID: NCT01788943
Lead Sponsor: University of PennsylvaniaOTHER
Brief Summary: The investigators propose to use positron emission tomography (PET) imaging to determine whether nicotinic receptor availability at pretreatment predicts smoking cessation success. The investigators will recruit 30 smokers from those enrolled in the Pharmacogenetics of Nicotine Addiction Treatment clinical trial. The investigators will measure nicotinic receptor availability using the PET radioligand 2-[18F]FA, after overnight abstinence and prior to initiation of treatment.

Status

Overall Status: Completed
Start Date: Feb 2013
Primary Completion Date: Jul 2015Actual
Completion Date: Jul 2015Actual

Study Record Dates

First Submitted: Feb 7, 2013
First Submitted that Met QC Criteria: Feb 8, 2013
First Posted: Feb 11, 2013Estimated
Last Update Submitted that Met QC Criteria: Aug 21, 2017
Last Update Posted: Mar 12, 2018Actual
Last Verified: Aug 2017

NCT01704573Completed

Nicotinic Receptor Levels After Stopping Smoking

NCT03442413Active, not recruiting

Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction

NCT04055467Completed

Brain Imaging in Tobacco Smokers During a Quit Attempt

NCT01038245Completed

Quantitation of Human Cerebral Nicotinie Receptors With 2[18F]FA-85380 and PET Healthy Non-smokers and Ex-Smokers and in Heavy and Light Situational Smokers

NCT01046513Completed

PET Imaging of Nicotinic Acetylcholine Receptors

NCT02514720Completed

Nicotine Metabolizers and [11C]-(+)-PHNO